Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$30.04 - $51.31 $286,641 - $489,600
-9,542 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$27.44 - $73.84 $261,832 - $704,581
9,542 New
9,542 $300,000
Q1 2018

May 15, 2018

SELL
$65.94 - $80.76 $1.12 Million - $1.37 Million
-17,000 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$43.47 - $67.43 $4.63 Million - $7.19 Million
-106,600 Reduced 86.25%
17,000 $1.12 Million
Q3 2017

Nov 13, 2017

BUY
$43.8 - $52.77 $5.41 Million - $6.52 Million
123,600
123,600 $6.19 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $120M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.